Barcelona, Spain

José María García Antón


Average Co-Inventor Count = 4.1

ph-index = 5

Forward Citations = 71(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of José María García Antón

Introduction

José María García Antón is a prominent inventor based in Barcelona, Spain. He has made significant contributions to the field of medicine through his innovative patents. With a total of seven patents to his name, his work focuses on compounds that inhibit neuronal exocytosis, which have important applications in treating various medical conditions.

Latest Patents

Among his latest patents are compounds that inhibit neuronal exocytosis, described by the general formula (I): R—W—X-AA-AA-AA-AA-AA-AA-AA-Y—Z—R. These compounds, along with their stereoisomers and mixtures, are designed for use in cosmetic or pharmaceutical compositions. They are particularly relevant in the treatment and prevention of pain, inflammation, itching, and various neurological and neuropsychiatric disorders. The compounds also play a role in the treatment and care of skin, hair, and mucous membranes mediated by neuronal exocytosis.

Career Highlights

José María García Antón has worked with notable companies in the industry, including Lipotec, S.A. and Lubrizol Advanced Materials, Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions in the pharmaceutical and cosmetic fields.

Collaborations

Throughout his career, he has collaborated with esteemed colleagues such as Antonio Vicente Ferrer Montiel and Raquel Delgado González. These partnerships have further enhanced his research and development efforts.

Conclusion

José María García Antón's contributions to the field of medicine through his innovative patents demonstrate his commitment to advancing healthcare solutions. His work continues to impact the treatment of various medical conditions, showcasing the importance of innovation in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…